2021
Associations of SARS-CoV-2 serum IgG with occupation and demographics of military personnel
Zell J, Wisnewski AV, Liu J, Klein J, Lucas C, Slade M, Iwasaki A, Redlich CA. Associations of SARS-CoV-2 serum IgG with occupation and demographics of military personnel. PLOS ONE 2021, 16: e0251114. PMID: 34460832, PMCID: PMC8405017, DOI: 10.1371/journal.pone.0251114.Peer-Reviewed Original ResearchConceptsSARS-CoV-2Live SARS-CoV-2Moderate SARS-CoV-2SARS-CoV-2 seroprevalenceWork-related risk factorsTransportation-related occupationsSerum IgG levelsAntigen-specific IgGIgG seropositivity rateBiomarkers of infectionSARS-CoV-2 spikeCOVID-19 exposureUS National Guard soldiersMilitary personnelIgG levelsSeropositivity rateHumoral responseSerum IgGViral exposureBlack raceRisk factorsOdds ratioStudy populationNational Guard soldiersDemographic data
2013
Amelioration of Acute Sequelae of Blast Induced Mild Traumatic Brain Injury by N-Acetyl Cysteine: A Double-Blind, Placebo Controlled Study
Hoffer ME, Balaban C, Slade MD, Tsao JW, Hoffer B. Amelioration of Acute Sequelae of Blast Induced Mild Traumatic Brain Injury by N-Acetyl Cysteine: A Double-Blind, Placebo Controlled Study. PLOS ONE 2013, 8: e54163. PMID: 23372680, PMCID: PMC3553161, DOI: 10.1371/journal.pone.0054163.Peer-Reviewed Original ResearchConceptsMild traumatic brain injuryN-acetyl cysteineTraumatic brain injuryBrain injuryOutcome measuresPlacebo-controlled studyPlacebo Controlled StudyLong-term outcomesMain outcome measuresReported side effectsService membersActive duty service membersU.S. service membersAcute sequelaeSymptom resolutionTerm outcomesControlled StudyNAC treatmentSleep disturbancesHearing lossNeurocognitive dysfunctionBaseline evaluationCivilian mild traumatic brain injuryBlast exposurePlacebo